Chemclin Diagnostics Co. Ltd. A (688468) — Financial Flexibility Index
Chemclin Diagnostics Co. Ltd. A (688468) has a Financial Flexibility Index of 0.12x as of September 2025. Free cash flow of CN¥43.57 Million (operating CF CN¥34.41 Million minus capex CN¥9.16 Million) represents 0% of total liabilities (CN¥363.17 Million). Check 688468 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chemclin Diagnostics Co. Ltd. A Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Chemclin Diagnostics Co. Ltd. A across 9 annual periods. See how liquid is Chemclin Diagnostics Co. Ltd. A's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Chemclin Diagnostics Co. Ltd. A (2017–2025)
Year-by-year free cash flow to debt coverage for Chemclin Diagnostics Co. Ltd. A. For the full company profile including market capitalisation, see market cap of Chemclin Diagnostics Co. Ltd. A.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.47x | CN¥163.78 Million | CN¥93.90 Million | CN¥350.05 Million | ▼ -29.4% |
| 2024 | 0.66x | CN¥275.44 Million | CN¥167.95 Million | CN¥415.85 Million | ▼ -39.7% |
| 2023 | 1.10x | CN¥474.43 Million | CN¥173.05 Million | CN¥431.76 Million | ▼ -37.4% |
| 2022 | 1.76x | CN¥369.84 Million | CN¥244.56 Million | CN¥210.59 Million | ▲ +2.3% |
| 2021 | 1.72x | CN¥261.40 Million | CN¥188.86 Million | CN¥152.23 Million | ▼ -12.8% |
| 2020 | 1.97x | CN¥235.26 Million | CN¥151.95 Million | CN¥119.46 Million | ▼ -2.9% |
| 2019 | 2.03x | CN¥256.52 Million | CN¥201.27 Million | CN¥126.42 Million | ▼ -16.4% |
| 2018 | 2.43x | CN¥196.18 Million | CN¥147.68 Million | CN¥80.87 Million | ▼ -16.8% |
| 2017 | 2.92x | CN¥192.89 Million | CN¥133.46 Million | CN¥66.15 Million | — |